can a avd replace pet-directed strategies for the frontline treatment of hodgkin lymphoma?
Published 1 year ago • 143 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:34
pet-guided treatment: the new standard of care in hodgkin lymphoma?
-
2:32
the use of pet and ctdna for risk stratification & to guide treatment decisions in hodgkin lymphoma
-
2:12
using pet to determine treatment response in hodgkin lymphoma
-
3:12
hodgkin lymphoma remission prolongation: post-asct strategies
-
2:00
updates on treatment methods for hodgkin lymphoma
-
16:13
3mensio ct pre-case planning: valve-in-valve tavr in trifecta
-
1:19
iv catheter full assembly line
-
3:16
identifying low- and high-risk aml
-
3:14
determining the optimal frontline treatment of aml
-
6:04
frontline treatment of hodgkin lymphoma
-
1:06
molecules versus cells for hodgkin lymphoma management
-
4:59
frontline treatment of transplant-ineligible mm: a changing landscape
-
3:09
treatment strategies for chl patients after auto-hsct
-
5:46
the use of allogeneic transplantation in the era of checkpoint blockade therapy in hodgkin lymphoma
-
3:23
frontline treatment options & chemotherapy response
-
2:25
jairus ibabao, md | medical oncology and hematology
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting
-
0:16
afib catheter ablation biomarker – two chamber view
-
17:11
transcatheter valve repair & replacement - dr. daniel s. levi | 2017 ucla achd symposium
-
1:13
utilizing pet/ct to improve staging in extranodal marginal zone lymphoma
-
14:00
optimizing quality & safety systems to reduce the risk of patient harm
-
1:41
the challenges with implementing car-t into the aml treatment landscape